Open AccessP481: MP0533, A NEW MULTISPECIFIC DARPIN CD3 ENGAGER TARGETING THREE TUMOR ASSOCIATED ANTIGENS, INDUCES SPECIFIC T‐CELL ACTIVATION AND AML TUMOR KILLING IN VIVO
Author(s) -
Croset A.,
Bianchi M.,
Franchini M.,
Lekishvili T.,
Kaufmann Y.,
Auge A.,
Hänggi M.,
Ali W.,
Zitt C.,
Wullschleger S.,
Matzner M.,
Reichen C.,
Fischer S.,
Grübler Y.,
Eggenschwiler A.,
Looser T.,
Watson R.,
Spitzli P.,
Kirkin V.,
Steiner D.,
Goubier A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844812.47753.bc
Subject(s) - chimeric antigen receptor , cancer research , in vivo , cytokine release syndrome , cd34 , t cell , stem cell , cd33 , antigen , transplantation , medicine , immunology , biology , immune system , microbiology and biotechnology